Diverse clinical trials provide more meaningful data to researchers, but too many trials are based around monolithic audience groups. In early disease detection, particularly in conditions like cancer, diversity in clinical trials is especially important. Our guests, Eucharia Borden of the cancer nonprofit Family Reach and Dr. Gary Puckrein of the National Minority Quality Forum, discuss why diversity in clinical trials is critical and how to foster inclusivity in clinical research, getting us closer to healthcare equity.  Help shape future episodes by taking our survey: https://bit.ly/3sQkbrN  Transcripts: https://grail.com/podcast/  Sign up for GRAIL's newsletter: https://grail.com/newsletter-signup/

Ver todos los episodios